Twist Bioscience Corporation Common Stock (TWST) Financials
Key financial figures for Twist Bioscience Corporation Common Stock (Q2 2026).
- Revenue
- $111M
- Net Income
- -$44M
- EPS
- $-0.71
- Total Assets
- $676M
- Operating Cash Flow
- -$18M
Full income statement, balance sheet, and cash flow for Twist Bioscience Corporation Common Stock on SentiSense.